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THE SUBSTANCE (±)-15-deoxysper-gualin (15-DS) is a derivative of sper-
gualin, a guanidinic-like structure. Its isola-
tion from Bacillus /aterosporus and antitu-
mor activity was described by Iwasawa et al. 1 
The substance was shown to be effective in 
experimental transplantation models with 
pancreas islet cells, heart, and kidney. 2•3 Espe-
cially with kidney antigen, specific nonreac-
tivity was achieved by 15-DS in long-term 
surviving individuals.4 Its immunopharmaco-
logical mode of actionwas evaluated by test-
ing its effects on lymphocytes and cells of the 
monocytejmacrophage group after in vivo 
and in vitro application. 
MATERIAL AND METHODS 
15-DS 
15-DS was kindly supplied by Dr Umezawa, Institute 
of Mierobial Chemistry, Tokyo. 
Animals 
NMRI miee (H-2c), F344 (RT1 1• 1 ), and LEW (RT1 1 ) 
rats were purehased from Charles River jWiga, Sulzfeld, 
FRG. DA (R n••I) and AS (R Tl 1) rats were bred and 
housed at the Department of Immunology, Kiel, FRG. 
Malerats were used at the age of 9 to 13 weeks. 
Cells ofthe Monocyte/Macrophage Group 
Chemiluminescence reaction. Two milliliters of 
heparinized peripheral venous blood was eolleeted by the 
puneture of the retroorbital vein plexus of rats. Mono-
eytes were separated by density gradient eentrifugation 
(800 x g, 20 minutes) over Ficoii-Hypaque (density, 
1.077 gjL). Monocytes were suspended in TCM 199 
containing penicillin, Streptomycin ( 100 U jmL each), 
and heparin (10 UjmL). Monocytes were stimulated by 
the addition of immune complexes (tetanus toxoid-antite-
tanus toxoid, formed at equivalence). The chemilumines-
cenee reaetion was performed in a Biolumate (Berthold 
Co, Wildbad, FRG, model LB9505) in the presence of 20 
~gjmL luminol in round-bottomed polystyrene vials 
(4 x 106 monoeytes/mL). The integral of relative light 
units (RLU) was calculated after 15 minutes by an Apple 
computer. 
Expression of major histocompatibility complex 
(MHC) class ll antigens. Spienie and peritoneal macro-
phages were primarily obtained by plastie adherence with 
Iactalbumin (eontaining 10% normal rat serum). For 
enrichment and purification of cells, a second period of 
adherence on glass cover slips (0, 12 mm, placed in 
24-well eulture plates) followed. Thus purified macro-
phages were incubated in vitro for one to four days with 
different concentrations of 15-DS in the presence of 9 
units of interferon (added for stabilization of the MHC 
class II antigen expression of the target eells; the normally 
oceurring rapid loss ofthese antigens in eulture could thus 
be completely avoided). After this culture period, eells 
were washed and fixed in 2% formalin before preparing 
them for immunoftuorescenee (fi.rst antibody, anti-rat 
MHC class li MRC-OX6, 1:70, 30 minutes, 4 °C in the 
dark; second antibody, anti-mouse IgG fluorescein iso-
thiocyanate, I :24, 30 minutes, 4 °C in the dark). Class 
li-positive cells were evaluated as a percentage of the 
total eell number. 
Lymphocytes 
Mitogen-induced proliferation of rat spienie 1ympho-
cytes (5 x 104/well) was determined in the presenee of 
coneanavalin A (Con A, 0.6 ~gjmL). The Stimulation 
index was defined as the ratio between mitogen-stimu-
lated 14C-thymidine ineorporation and the unstimulated 
control. 
Plaque-forming cells (IgM-secreting cells) were deter-
mined with mousespienie lymphocytes (2.5 x 105 ) after 
in vitro incubation with 106 sheep RBC for 48 hours. 
In mixed lymphocyte culture (MLC), LEW respander 
spieen eells ( 1 05 ) were cocultiva ted with mitomycin C-
blocked DA stimulator spieen eells (5 x 105 ) for five 
days. 15-DS was added to the culture medium in nine 
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different concentrations ranging from 0.1 to 400 IJ.g/mL 
culture medium. 
Skin Transplantation 
Tail skin pieces (0.5 x l cm) for LEW rats were 
grafted to the tails of F344 rats. Rejection was defined as 
the time the graft was of red-brown color and of hard 
consistency. 
RESULTS 
Skin Transplantation 
Rejeetion of skin grafts in the MHC-
different LEW-to-F344 system oeeurred after 
about 15 days in normal untreated rats. When 
graft reeipients were treated intraperitoneally 
with 0.5 to 2.0 mgjkg 15-DS, about a dou-
bling of graft survival time was observed. 
Larger amounts of the drug (5.0 or 10.0 
mgjkg) were mueh less useful or were ineffee-
tive (Table 1 ). Per os (PO) administration of 
15-DS led to similar or even better results. 
The optimal dose (about a threefold inerease 
in graft survival) was shown to be in the range 
of 20 mgjkg. The higher eoneentrations 
required with PO administration suggest that 
only a part of the substanee was absorbed 
unaltered via the enterie raute. 
Monocyte and Lymphocyte In Vitro Activity 
After Multiple In Vivo Administration 
Under similar eonditions, as deseribed for 
the skin transplantation experiments, the 
effeets of 15-DS on monoeyte and lymphoeyte 
funetions were examined in vitro. F344 rats 
were treated ten times with 2 mgjkg 15-DS 
Table 1. Survival Time of Tail Skin Grafts (LEW-
F344) After IP or PO Administration of 15-DS 
IP PO 
Graft Survival Timet Graft Survival Timet 
mg/kg* (Days, mean ±SO) mg/kg* (Days, mean ± SD) 
0 14.8 ± 1.5 0 15.4 ± 2.5 
0.5 29.4 ± 2.4 2.5 21.5 ± 3.4 
2.0 27.4±3.3 5.0 22.2 ± 3.6 
5.0 15.0 ± 0 10.0 25.5 ± 4.9 
10.0 17.6 ± 2.2 20.0 40.5 ± 8.4 
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intraperitoneally (IP). On the days indieated 
in Table 2, the aetivities of either monoeytes 
or lymphoeytes were examined. The ehemilu-
mineseenee reaetion of peripheral blood 
monoeytes was distinetively suppressed to 
25%. Suppression lasted for at least 2 weeks. 
On the other hand, the mitogen (Con A) 
indueed proliferation of F344 spienie lympho-
eytes was not affeeted signifieantly by 15-
DS. 
Expression of MHC Cl(lss !I Antigens on 
M acrophages 
The variation of MHC class II (Ia +) anti-
gen expression of normal rat maerophages in 
vitro under the influenee of 15-DS was exam-
ined by immunofluoreseenee following one to 
four days of eultivation of the eells in the 
presenee of0.01 to 500 1-Lg/mL 15-DS. Figure 
1 A shows a signifieant dose-dependent 
deerease of class II antigen expression on 
spienie maerophages by 25% in the highest 
drug eoneentration in vitro. The effeets are 
time independent as ean be seen from the 
nearly identieal patterns of reaetivity on days 
1, 2, and 4. The immunosuppressive effeet of 
15-DS is also visible three days after in vivo 
treatment of the rats with a single IP injeetion 
Table 2. Effect of Multiple ln Vivo Administrations of 
15-DS on Monocytes and lymphocytes 
Monocytes Lymphocytes 
Chemiluminescence Con A-lnduced 
Reaction• Proliferation t 
Day (Percentage of Control) Day (Percentage of Gontroll 
0 100 0 100 
3 82 3 82 
6 57 5 103 
8 56 10 73 
10 38 13 99 
13 28 21 125 
1 5-DS was administered in doses of 2 mg/kg on days 
0 to 9. 
Abbreviation: Gon A, concanavalin A. 
*RLU/15 minutes x 103 in the presence of immune 
complexes ( 100% = 3,545 ± 499 RLU/ 15 minutes X 1 0 3 ), 
* 15-DS was given 10 x (days 0 to 9). n = 3 experiments/day. 
tRejection time wasdiagnosedas the day when the graft tStimulation index control (100%) = 20 ± 4.5 in the 
was of red-brown color and of hard consistency, n = 5. presence of 0.6 iJ.Q/mL Gon A, n = 6 experiments/d. 
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Fig 1. Time- and concentration-dependent inhibi-
tion of MHC class II antigen expression of macrophages 
by 15-DS (Al after in vitro and (BI in vivo application; 
n = 9 experiments per day and concentration. 
of 10 mgjkg 15-DS (Fig 1B). The decrease 
obtained is more pronounced on peritoneal 
macrophages ( 16%, P::; .05) than on spienie 
macrophages (8%, P ;:::: .05) possibly due to a 
direct v indirect effect of the drug. 
In Vitra lnfluence of 15-DS on 
Macrophage-Dependent Lymphocyte 
Function 
I t was determined w hether 15-DS could 
inhibit the MLC and the plaque-forming cell 
(PFC) response. Figure 2 shows a dase-rlepen-
dent decrease of the MLC by 15-DS. Inhibi-
tion increasing from >60% to >90% is 
achieved by drug concentrations ranging from 
10 to 400 f.Lg/mL. In the PFC assay, 15-DS 
was added in four concentrations from 0.1 to 
100 f.Lg/mL into the culture medium. Similar 
to the MLC, a dose-dependent reduction of 
IgM-secreting lymphocytes was observed; an 
IC50 value of 2 f.Lg/mL was calculated. 
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Fig 2. Concentration-dependent inhibition of MLC 
(0--01 and PFC (0-01 by 15-DS. MLC. N = 5 experi-
ments/concentration; PFC. 100% value (controll = 
1,493 ± 61, n = 5 experiments/concentration. 
DISCUSSION 
15-DS, a new immunesuppressive drug 
with predominant activity against cells of the 
monocytejmacrophage group was tested in 
vivo and in vitro in a variety of experimental 
models. 
Skin graft survival was effectively pro-
longed in an MHC variant strain combina-
tion. Bearing in mind the well-known strong 
immunogenicity of skin, the data presented 
here upon IP or PO administration of this 
drug appear tobe remarkable. They are com-
patible with the data obtained with fully allo-
geneic kidney grafts suggesting that 15-DS is 
as powerful as cyclosporine A (CsA).4 
Although the suppression of chemilumines-
cence already hints towards an inhibitory 
influence by 15-DS on cells of the monocyte-
macrophage group, the downregulation of 
MHC class II antigen expression may be 
regarded as providing a further step towards 
elucidation of its mode of action. How far this 
applies to other cells of this group such as the 
nonphagocytic, highly immunogenic dendritic 
cells is under investigation. 
Although the clearly different effects of 
15-DS on functions of monocytes and lympho-
cytes, analyzed in vitro following in vivo appli-
cations of the drug, support the notion of an 
immunosuppressive activity of 15-DS, pre-
dominantly against cells of the monocyte/ 
macrophage group, this requires further in 
1304 
vitro analysis. The remarkably strong effect of 
15-DS on macrophage-dependent lymphocyte 
functions following in vitro application of the 
drug will allow us to further clarify this point 
by separately treating one or the other of the 
cooperating cells. In particular, MLC inhibi-
tionsturlies may indicate how far MHC class 
II antigen expression-related graft immuno-
genicity depression may be involved in addi-
tion to a depression of the function of antigen-
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presenting macrophages on the side of the 
responder. 
Obviously, a preferential effect of 15-DS on 
antigen-presenting cell functions would lead 
to the suggestion of combining this drug with 
another that preferentially acts on T lympho-
cytes such as CsA. It is the distinct possibility 
of potentiating immunosuppressive effects by 
interfering at a different cellular site that 
appears to make 15-DS interesting. 
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